The current stock price of KEQU is 39.2 USD. In the past month the price decreased by -13.57%. In the past year, price decreased by -10.3%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.67 | 222.97B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.23 | 201.33B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.84 | 143.55B | ||
| SYK | STRYKER CORP | 27.96 | 140.79B | ||
| IDXX | IDEXX LABORATORIES INC | 57.57 | 58.07B | ||
| BDX | BECTON DICKINSON AND CO | 13.36 | 55.24B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| RMD | RESMED INC | 25.33 | 36.59B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.66 | 34.82B | ||
| DXCM | DEXCOM INC | 32.38 | 23.62B | ||
| PODD | INSULET CORP | 72.47 | 23.30B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.39 | 18.26B |
Kewaunee Scientific Corp. engages in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company is headquartered in Statesville, North Carolina and currently employs 1,239 full-time employees. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The firm's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. The company has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
KEWAUNEE SCIENTIFIC CP
2700 W Front St
Statesville NORTH CAROLINA 28677 US
CEO: Thomas D. Hull
Employees: 1239
Phone: 17048737202
Kewaunee Scientific Corp. engages in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company is headquartered in Statesville, North Carolina and currently employs 1,239 full-time employees. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The firm's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. The company has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
The current stock price of KEQU is 39.2 USD. The price increased by 4.51% in the last trading session.
KEQU does not pay a dividend.
KEQU has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The next ex-dividend date for KEWAUNEE SCIENTIFIC CP (KEQU) is September 9, 2019.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on KEQU.
You can find the ownership structure of KEWAUNEE SCIENTIFIC CP (KEQU) on the Ownership tab.
ChartMill assigns a fundamental rating of 5 / 10 to KEQU. Both the profitability and the financial health of KEQU get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months KEQU reported a non-GAAP Earnings per Share(EPS) of 4.14. The EPS decreased by -33.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.68% | ||
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| Debt/Equity | 0.91 |